Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | JNJ | REGN |
|---|
| Close | 270.22 | 789.45 |
| Market Cap | $644B | $79.7B |
| 1M | −0.33% | −2.57% |
| P/E (TTM) | 30.6 | 18.5 |
| Forward P/E | 20.7 | 14.1 |
| P/E 5-Yr Percentile | 90 | 48 |
| P/S | 6.6 | 5.2 |
| P/B | 7.6 | 2.5 |
| Dividend Yield | 3.12% | 0.47% |
| Latest Quarter Revenue | $25.3B | $4.3B |
| Revenue YoY | +6.6% | +16.7% |
| Gross Margin | 68.2% | — |
| Latest Quarter EPS | 2.27 | 12.23 |
| Avg Post-Earnings Move | ±0.6% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.25% | 4.61% |
| 90-Day Net Insider Buying | −$67.8M | −$3.4M |
JNJ · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
